Nippon Kayaku Co., Ltd. (NPKYF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 12.16 means the share price is 12.16 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $1.24B is the value of all shares combined. Beta 0.49: the stock has moved about 51% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerNippon Kayaku Co., Ltd. (NPKYF) trades at $8.44. Nippon Kayaku Co., Ltd. is a diversified Japanese global enterprise manufacturing functional chemicals, pharmaceuticals, safety systems, and agrochemicals, serving various industries worldwide. Market cap: $1.24B, Sector: Basic materials.
Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for NPKYF: NPKYF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NPKYF against Basic Materials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
NPKYF: 2/2 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Nippon Kayaku Co., Ltd. (NPKYF) Materials & Commodity Exposure
Nippon Kayaku Co., Ltd. is a Japanese diversified manufacturer operating globally across functional chemicals, pharmaceuticals, safety systems, and agrochemicals. With a history spanning over a century, the company provides advanced materials, therapeutic solutions, automotive safety components, and agricultural products to diverse international markets, underpinned by a 10.2% profit margin.
What Is the Investment Thesis for NPKYF?
Nippon Kayaku Co., Ltd. presents a diversified investment profile, characterized by its presence across essential industries including functional chemicals, pharmaceuticals, safety systems, and agrochemicals. The company's robust operational structure is reflected in its current P/E ratio of 12.16 and a healthy profit margin of 10.2%, alongside a gross margin of 30.1%, indicating efficient cost management and profitability. A dividend yield of 3.16% offers income potential, while a low Beta of 0.49 suggests lower volatility relative to the broader market. Key value drivers include its established market positions in specialized chemical materials crucial for advanced electronics and automotive safety, and its pharmaceutical pipeline focusing on oncology and biosimilars. Growth catalysts are anticipated from ongoing innovation in MEMS materials, expanding demand for automotive safety components, and the global need for agricultural solutions. The company's long operational history since 1916 and global reach further underpin its stability. Potential risks include commodity price fluctuations impacting chemical segments, regulatory changes in pharmaceuticals, and intense competition across its diverse markets.
Based on FMP financials and quantitative analysis
NPKYF Key Highlights
Market capitalization of $1.24B reflects its established presence in diversified industrial sectors.
- A P/E ratio of 12.16 indicates a valuation below the broader market average, potentially signaling value.
- Profit margin of 10.2% demonstrates efficient operations and strong bottom-line performance across its varied business segments.
- Gross margin of 30.1% highlights effective cost management in production and a competitive pricing strategy for its products.
- A dividend yield of 3.16% provides an attractive return to shareholders, supported by consistent profitability.
Who Are NPKYF's Competitors?
NPKYF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| HUN Huntsman Corporation | $9.53 | -0.52% | $1.67B | 335-pillar |
| BAK Braskem S.A. | $2.10 | -0.24% | $839M | 415-pillar |
| LXU LSB Industries, Inc. | $11.55 | -0.64% | $831M | 755-pillar |
| WLKP Westlake Chemical Partners LP acquires, develops, and | $21.52 | +0.23% | $758M | 895-pillar |
| TROX Tronox Holdings plc | $4.61 | +0.33% | $735M | — |
| DENKF Denka Company Limited | $28.00 | 0.00% | $2.41B | 499-signal |
| RYAM Rayonier Advanced Materials Inc. | $8.35 | -1.65% | $563M | — |
| VHI Valhi, Inc. | $18.15 | -1.04% | $514M | 565-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are NPKYF's Key Strengths?
Highly diversified business model across functional chemicals, pharmaceuticals, safety systems, and agrochemicals.
- Strong historical presence and established brand reputation since 1916.
- Proprietary technology and expertise in specialized chemical and material science applications.
- Global operational footprint serving international markets.
- Solid financial metrics including a 10.2% profit margin and 3.16% dividend yield.
What Are NPKYF's Weaknesses?
Exposure to commodity price fluctuations in its chemical segments.
- Potential for intense competition across all diversified business areas.
- Reliance on regulatory approvals and R&D success in the pharmaceutical sector.
- Complexity in managing a highly diversified global supply chain.
- Unknown disclosure status on the OTC market may impact investor confidence.
What Could Drive NPKYF Stock Higher?
NPKYF catalyst: Expansion of advanced functional materials into new high-growth electronics applications, potentially driving increased revenue from the Functional Chemicals Business segment.
- Continued development and market penetration of biosimilars and oncology drugs within the Pharmaceuticals Business segment, capitalizing on expiring patents and global healthcare demand.
- Adoption of new automotive safety regulations globally, which could increase demand for Nippon Kayaku's airbag inflators and micro gas generators.
- Strategic partnerships or collaborations in the agrochemicals sector to develop and distribute new, more effective agricultural solutions.
- Introduction of new diagnostic applications or expanded clinical use cases for GlycoMark in diabetes management, boosting pharmaceutical segment growth.
What Are the Key Risks for NPKYF?
Fluctuations in raw material prices, particularly for chemicals, could impact the profitability of the Functional Chemicals and Agrochemicals segments.
- Intense competition across all four primary business segments, potentially leading to pricing pressures and market share erosion.
- Adverse regulatory changes or delays in product approvals within the Pharmaceuticals Business segment could hinder new drug launches and revenue growth.
- Global economic slowdowns or disruptions in the automotive industry could negatively affect demand for Safety Systems components.
- Currency exchange rate volatility, given its global operations and headquarters in Japan, could impact reported earnings and international competitiveness.
What Are the Growth Opportunities for NPKYF?
- Expansion in Advanced Functional Materials: Nippon Kayaku's functional chemicals segment, particularly its offerings like photoresists and insulating materials for micro-electromechanical systems (MEMS), and specialized sealants for LCDs and LEDs, represents a significant growth avenue. The global MEMS market is projected to continue expanding, driven by demand in consumer electronics, automotive, and industrial applications. By innovating and expanding its portfolio of high-performance resins and optical components, Nippon Kayaku can capitalize on the increasing integration of advanced materials in next-generation devices and displays, securing a larger share in these high-value markets with projected growth over the next 5-7 years.
- Leveraging Pharmaceutical Innovation in Oncology and Biosimilars: The Pharmaceuticals Business segment, with its focus on oncology drugs, biosimilars, and generic medications, offers substantial growth potential. The global oncology market continues to grow due to an aging population and advancements in cancer treatment. Nippon Kayaku's investment in biosimilars allows it to capture market share as patents expire on blockbuster biologics, providing cost-effective alternatives. Expanding its pipeline and market penetration for these therapeutic solutions, particularly in emerging markets, could drive revenue growth over the medium to long term, addressing critical healthcare needs and capitalizing on market shifts towards more accessible treatments.
- Capitalizing on Global Automotive Safety Standards: The Safety Systems Business, manufacturing critical components like airbag inflators and micro gas generators for seatbelt pretensioners, is poised for growth due to increasingly stringent global automotive safety regulations and rising vehicle production volumes. As automotive manufacturers prioritize occupant safety and integrate more advanced safety features, the demand for Nippon Kayaku's specialized components is expected to rise. Strategic partnerships with major automotive OEMs and continuous innovation in safety system technology could solidify its market position and drive consistent revenue growth over the next decade, aligning with the evolution of autonomous driving technologies.
- Addressing Agricultural Productivity and Public Health Needs: The Agrochemicals segment, which provides insecticides, herbicides, and soil fumigants for agriculture and public hygiene, addresses fundamental global challenges. With a growing global population, the demand for increased agricultural output and effective pest control solutions remains high. Nippon Kayaku can expand its market share by developing and distributing more environmentally sustainable and highly effective agrochemical products. Furthermore, its public hygiene insecticides contribute to global health initiatives, offering a stable demand base. This segment's growth is tied to global food security trends and public health concerns, offering long-term stability and expansion opportunities.
- Expanding Diabetes Management Solutions with GlycoMark: The Pharmaceuticals Business segment's offering of GlycoMark, a key biomarker for managing blood glucose levels in diabetes, presents a specialized growth opportunity. As the global prevalence of diabetes continues to rise, the demand for effective diagnostic and monitoring tools is increasing. By expanding the market reach and clinical adoption of GlycoMark, Nippon Kayaku can tap into the growing diabetes care market. This involves strategic marketing, physician education, and potentially developing new applications or improved versions of the biomarker, positioning it as a crucial tool in personalized diabetes management and contributing to sustained revenue growth in a critical healthcare niche.
What Threats Does NPKYF Face?
- Economic downturns impacting demand across industrial and consumer sectors.
- Rapid technological shifts or disruptive innovations from competitors.
- Stricter environmental regulations affecting chemical and agrochemical production.
- Patent expirations and increased generic competition in the pharmaceutical segment.
- Geopolitical risks and trade barriers impacting international operations and supply chains.
What Are NPKYF's Competitive Advantages?
- Proprietary technologies and specialized expertise in developing high-performance functional chemicals and advanced materials.
- Established relationships and supply chain integration with major automotive OEMs for safety systems components.
- Regulatory approvals and clinical development expertise in the pharmaceutical sector, particularly for oncology and biosimilars.
- Diversified product portfolio across multiple essential industries, reducing reliance on any single market segment.
- Long-standing operational history since 1916, fostering brand recognition and trust in its core markets.
What Does NPKYF Do?
Nippon Kayaku Co., Ltd., a global enterprise headquartered in Tokyo, Japan, has been a significant player in various industrial sectors since its establishment in 1916 as Nihon Kayaku Seizou Co., Ltd., later rebranding in 1945. The company, along with its subsidiaries, manufactures and distributes a diverse portfolio of products across four core business segments: functional chemicals, pharmaceuticals, safety systems, and agrochemicals, serving markets both within Japan and internationally. Its Functional Chemicals Business segment is a comprehensive supplier of advanced materials, encompassing a wide array of products such as epoxy and UV-curable resins, specialized sealants for LCDs and LEDs, maleimide resins, and photoresists and insulating substances crucial for micro-electromechanical systems (MEMS). This segment also produces various cleaning agents, general chemicals, colorants for inkjet, textile, and paper applications, and thermal paper materials. Furthermore, it develops catalysts vital for acrylic and methacrylic acid production and manufactures optical and display components, including polarizing films, inorganic polarizers, and parts for LCDs, projectors, and X-ray analysis, demonstrating its commitment to high-tech material innovation. The Pharmaceuticals Business segment is dedicated to therapeutic solutions, offering a range of oncology drugs, including anti-cancer and cancer-related medications, biosimilars, and generic drugs. It also extends into interventional radiology and cardiovascular treatments, supplying bulk drug substances and pharmaceutical intermediates. Additionally, this segment provides diagnostic agents for cancer and markets GlycoMark, a key biomarker for managing blood glucose levels in diabetes. Within the Safety Systems Business, Nippon Kayaku is a critical manufacturer of automotive safety components, producing essential items such as airbag inflators, micro gas generators used in seatbelt pretensioning systems, and squibs, contributing significantly to vehicle occupant protection. The Agrochemicals segment supports agricultural productivity and public health by offering a range of products, including insecticides for both agriculture and public hygiene, herbicides, and soil fumigants. Beyond its extensive manufacturing operations, the company also engages in real estate leasing, diversifying its revenue streams.
What Products and Services Does NPKYF Offer?
- Manufacture and distribute functional chemicals including epoxy resins, UV-curable resins, and sealants for LCDs and LEDs.
- Produce advanced materials like photoresists and insulating substances for micro-electromechanical systems (MEMS).
- Develop and supply colorants for inkjet, textile, and paper applications, as well as thermal paper materials.
- Provide a range of pharmaceuticals, including anti-cancer drugs, biosimilars, generic medications, and cardiovascular treatments.
- Manufacture critical automotive safety components such as airbag inflators, micro gas generators, and squibs.
- Offer agrochemical products, including insecticides, herbicides, and soil fumigants for agriculture and public health.
- Supply catalysts for industrial chemical production and optical components for displays and X-ray analysis.
- Engage in real estate leasing services as a supplementary business activity.
How Does NPKYF Make Money?
- Revenue generation through the sale of specialized functional chemicals and advanced materials to electronics, automotive, and industrial clients.
- Sales of pharmaceutical products, including branded oncology drugs, biosimilars, and generics, to healthcare providers and pharmacies.
- Supply of automotive safety components directly to original equipment manufacturers (OEMs) in the automotive industry.
- Distribution of agrochemical products to agricultural sectors and public health organizations globally.
- Income derived from real estate leasing activities, providing a diversified revenue stream.
What Industry Does NPKYF Operate In?
Nippon Kayaku Co., Ltd. operates within the broad Basic Materials sector, specifically positioned in the Chemicals industry, but with significant diversification into Pharmaceuticals, Automotive Safety Systems, and Agrochemicals. The global chemicals market is characterized by ongoing demand for specialized materials driven by technological advancements in electronics, automotive, and healthcare sectors. Nippon Kayaku's functional chemicals segment, supplying materials for LCDs, LEDs, and MEMS, directly benefits from trends in miniaturization and high-performance computing. In pharmaceuticals, the company competes in the oncology, biosimilar, and generic drug markets, which are influenced by aging populations and increasing healthcare expenditures. The automotive safety systems segment is propelled by stringent global safety regulations and increasing vehicle production. Its agrochemicals division addresses global food security and public health challenges. This diversified approach allows Nippon Kayaku to mitigate risks associated with cyclicality in any single industry, positioning it as a multifaceted player within several critical global markets.
Who Are NPKYF's Key Customers?
- Electronics manufacturers utilizing advanced resins, sealants, and optical components for LCDs, LEDs, and MEMS.
- Automotive industry OEMs purchasing airbag inflators, micro gas generators, and squibs for vehicle safety systems.
- Healthcare providers, hospitals, and pharmacies acquiring oncology drugs, biosimilars, and generic medications.
- Agricultural enterprises and farmers using insecticides, herbicides, and soil fumigants for crop protection.
- Public health organizations and municipalities employing insanitary insecticides for pest control.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
- ● Reported in JPY, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 48 |
| 2026-08-26 | 48 |
| 2026-08-29 | 48 |
| 2026-09-01 | 48 |
| 2026-09-04 | 48 |
| 2026-09-07 | 48 |
| 2026-09-10 | 48 |
What changed?
The score has stayed at 48.
Over the same 18 days the stock moved +0.0%.
Company Profile
Nippon Kayaku Co., Ltd. operates in the Chemicals industry within the Basic Materials sector. It is headquartered in Tokyo, JP. The company is led by CEO Shigeyuki Kawamura. NPKYF has traded publicly since 2018.
Key Financial Metrics
Return on equity for Nippon Kayaku Co., Ltd. stands at 9.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.2%, showing how much profit it generates from its asset base. NPKYF trades at a trailing price-to-earnings ratio of 12.16, below the Basic Materials sector average of ~21.40x. A current ratio of 3.38 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 8.2%, the inverse of the P/E and a quick read on earnings relative to price.
NPKYF Valuation & Market Position
With a $1.24B market cap, Nippon Kayaku Co., Ltd. sits in the small-cap segment of the market.
Quarterly Financial Performance: Nippon Kayaku Co., Ltd.
Revenue for Nippon Kayaku Co., Ltd. came in at $435.4M during Q1 FY2027, a 1.1% contraction versus the preceding quarter. The company recorded net income of $39.3M, with diluted EPS of $0.27. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Basic Materials. Across the four most recent quarters, NPKYF averaged $0.29 in diluted EPS.
Financial Health
Nippon Kayaku Co., Ltd.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.76 places it in the grey zone, a middle ground that warrants monitoring.
NPKYF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Highly diversified business model across functional chemicals, pharmaceuticals, safety systems, and agrochemicals.
- Strong historical presence and established brand reputation since 1916.
- Proprietary technology and expertise in specialized chemical and material science applications.
- Global operational footprint serving international markets.
Bear Case
- Exposure to commodity price fluctuations in its chemical segments.
- Potential for intense competition across all diversified business areas.
- Reliance on regulatory approvals and R&D success in the pharmaceutical sector.
- Complexity in managing a highly diversified global supply chain.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 FY2027 | $435M | $39M | $0.27 |
| Q4 FY2026 | $440M | $48M | $0.32 |
| Q3 FY2026 | $397M | $37M | $0.24 |
| Q2 FY2026 | $388M | $49M | $0.32 |
Q1 FY2027 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Converted to USD from JPY at today's rate
NPKYF Latest News
No recent news available for NPKYF.
NPKYF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NPKYF.
Price Targets
Wall Street price target analysis for NPKYF.
NPKYF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NPKYF; grades run from A+ (80-100) to F (below 30).
Leadership: Shigeyuki Kawamura
Chief Executive Officer
Shigeyuki Kawamura serves as the Chief Executive Officer of Nippon Kayaku Co., Ltd., overseeing a global workforce of 5902 employees across its diverse business segments. His leadership is critical in guiding the company's strategic direction, operational excellence, and innovation initiatives. As CEO, Mr. Kawamura is responsible for managing a complex enterprise that spans functional chemicals, pharmaceuticals, safety systems, and agrochemicals, requiring a comprehensive understanding of various industrial landscapes, market dynamics, and regulatory environments. His career history likely includes extensive experience in executive management within large, diversified manufacturing or technology-focused corporations, demonstrating a proven ability to lead multi-faceted operations.
Track Record: Under Shigeyuki Kawamura's leadership, Nippon Kayaku Co., Ltd. has maintained its position as a diversified global manufacturer, navigating complex market conditions across its core segments. His strategic decisions are focused on fostering innovation in advanced materials, expanding the pharmaceutical pipeline, and ensuring the continued reliability and quality of automotive safety systems. Mr. Kawamura's tenure has been marked by efforts to optimize operational efficiencies and drive sustainable growth across the company's global footprint, ensuring the company remains competitive and responsive to evolving market demands in its specialized fields.
NPKYF OTC Market Information
Nippon Kayaku Co., Ltd. trades on the OTC market under the 'OTC Other' tier. This tier represents companies that do not meet the disclosure requirements for OTCQX or OTCQB, the higher tiers of the OTC market. Companies in the 'OTC Other' tier typically provide limited or no public disclosure, which can make it challenging for investors to access comprehensive financial and operational information. Unlike companies listed on major exchanges like NYSE or NASDAQ, which have stringent reporting requirements, 'OTC Other' companies operate with less regulatory oversight regarding financial transparency and corporate governance standards.
- OTC Tier: OTC Other
- Limited public disclosure and transparency, making it difficult to assess financial health and operational performance.
- Lower liquidity and wider bid-ask spreads, potentially leading to challenges in trading and price volatility.
- Lack of stringent regulatory oversight compared to major exchanges, increasing potential for fraud or manipulation.
- Difficulty in obtaining reliable and timely financial information for due diligence.
- Potential for delisting or further restrictions if disclosure standards are not met or improved.
- Verify the company's official website and investor relations section for any available financial reports or press releases.
- Research the company's business operations, products, and market position through independent sources.
- Examine any available historical financial data, even if unaudited, to understand revenue and profitability trends.
- Investigate the management team's background and track record, looking for any red flags or positive indicators.
- Assess the company's market capitalization and trading volume to gauge liquidity and market interest.
- Consult with a financial advisor experienced in OTC markets to understand specific risks and opportunities.
- Review any news or regulatory filings from Japanese authorities, given its HQ in Tokyo, for additional insights.
- Long operational history since 1916, indicating a well-established company.
- Diversified business across multiple industrial sectors (chemicals, pharma, safety, agrochemicals).
- Global presence and operations, suggesting a broader market reach and established infrastructure.
- Significant employee base (5902 employees), indicative of a substantial operational scale.
- Headquartered in Tokyo, Japan, a major global financial and industrial hub.
Common Questions About NPKYF (Basic Materials)
Is NPKYF a good stock?
Stock Expert AI does not rate NPKYF buy, sell or hold. Nippon Kayaku Co., Ltd. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Nippon Kayaku Co., Ltd. do?
Nippon Kayaku Co., Ltd. is a diversified Japanese manufacturing company with a global presence, operating across four primary business segments.
What are the key factors to evaluate for NPKYF?
Evaluate NPKYF on fundamentals, analyst consensus, and risk factors. P/E: 12.16x vs the S&P 500's ~20-25x. A dividend yield of 3.16% offers income potential, while a low Beta of 0.49 suggests lower volatility relative to the broader market. Not financial advice.
How frequently does NPKYF data refresh on this page?
NPKYF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NPKYF's recent stock price performance?
Nippon Kayaku Co., Ltd. (NPKYF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Highly diversified business model across functional chemicals, pharmaceuticals, safety systems, and agrochemicals. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NPKYF overvalued or undervalued right now?
Nippon Kayaku Co., Ltd. (NPKYF) trades at 12.16x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of NPKYF?
Yes, most major brokerages offer fractional shares of Nippon Kayaku Co., Ltd. (NPKYF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track NPKYF's earnings and financial reports?
Nippon Kayaku Co., Ltd. (NPKYF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for NPKYF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC Analysis is based on general characteristics of the 'OTC Other' tier and 'Unknown' disclosure status, as specific company-level OTC details were limited.